Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiotech Pharmaceuticals
Angiotech selects independent sales rep in Japan for contour threads product line
August 18th, 2006
Angiotech Pharmaceuticals, Inc., (ANPI, ANP) has signed an agreement with KMT Japan to sell Angiotech's Contour Threads product line in Japan, which is the ninth largest aesthetics market worldwide according to the International Society of Aesthetic Plastic Surgery (ISAPS). These top 10 countries combined perform approximately 68% of all global aesthetic procedures. "We continue to expand our reach in the growing Asia-Pacific market with this new distribution agreement. For the first time, people in Japan will have the option of a minimally-invasive facelift procedure performed with Contour Threads products," said William Hunter, president and CEO of...
Source: Biotech Law Weekly (2006-08-18)
|
